Author: Evan Dion

Apple Suppliers Losing Ground in Sympathy With Sales Warning

Apple’s (AAPL) surprise sales warning late Wednesday is reverberating throughout the technology sector as its legion of suppliers go down with the ship. With more than 200 companies participating in the manufacture of Apple products, the fallout spreads across nearly every sector of the tech-heavy Nasdaq Composite. While most vendors are located in China, many trade on the NYSE resulting […]

Mortgage Applications Extend Decline as Investors Lean Toward US Treasuries

Mortgage applications fell sharply in the final week of 2018, extending a downward trend which has seen declining consumer demand for traditional home purchase financing as investors continued to show a preference for safer US treasuries. Applications for mortgages fell by nearly 10% from two weeks earlier, according to survey data from the Mortgage Bankers’ Association (MBA) which covered more […]

Ohr Pharmaceuticals Surges 82% On Merger Agreement With NeuBase Therapeutics Inc.

Ohr Pharmaceuticals Surges 82% On Merger Agreement With NeuBase Therapeutics Inc.

Ohr Pharmaceuticals (OHRP) soared more than 82% in pre-market trade on Thursday after the company said it has agreed to merge with NeuBase Therapeutics Inc. Stockholders of NeuBase would become the majority holders of the combined company. The proposed merger will create a public company focused on advancing NeuBase’s peptide-nucleic acid antisense oligonucleotide, or PATrOL, technology platform to develop therapies […]